CORD-19:12d35c12218f230c49f4dc892814ba9f1037f251 / 35108-35372 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T169","span":{"begin":0,"end":264},"obj":"Sentence"}],"text":"Cottontop tamarins vaccinated with a VACV-WRbased recombinant expressing the gp340 envelope antigen of Epstein-Barr virus (EBV) were protected against EBV-induced lymphoma, but animals inoculated with the attenuated Wyeth (VACV-NYCBOH)-based recombinant, were not."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T169","span":{"begin":0,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Cottontop tamarins vaccinated with a VACV-WRbased recombinant expressing the gp340 envelope antigen of Epstein-Barr virus (EBV) were protected against EBV-induced lymphoma, but animals inoculated with the attenuated Wyeth (VACV-NYCBOH)-based recombinant, were not."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T18","span":{"begin":163,"end":171},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0002665"}],"text":"Cottontop tamarins vaccinated with a VACV-WRbased recombinant expressing the gp340 envelope antigen of Epstein-Barr virus (EBV) were protected against EBV-induced lymphoma, but animals inoculated with the attenuated Wyeth (VACV-NYCBOH)-based recombinant, were not."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T140","span":{"begin":163,"end":171},"obj":"Disease"},{"id":"T98227","span":{"begin":163,"end":171},"obj":"Disease"}],"attributes":[{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"},{"id":"A46827","pred":"mondo_id","subj":"T98227","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"}],"text":"Cottontop tamarins vaccinated with a VACV-WRbased recombinant expressing the gp340 envelope antigen of Epstein-Barr virus (EBV) were protected against EBV-induced lymphoma, but animals inoculated with the attenuated Wyeth (VACV-NYCBOH)-based recombinant, were not."}